Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1425 of 2228 entries
View as:

To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02093819 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT02300311 Org: User:
Start: 01/31/15 End: 05/31/15 Due: 05/31/16

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02084082 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

Linagliptin as Add on to Basal Insulin in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT02240680 Org: User:
Start: 09/23/14 End: 04/25/17 Due: 04/25/18

Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT02256787 Org: User:
Start: 01/31/04 End: - Due: -

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00806819 Org: User:
Start: 12/31/08 End: 12/31/15 Due: 12/31/16

Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT02182882 Org: User:
Start: 03/31/99 End: - Due: -

A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

Phase: N/A Priority: Normal
NCT ID: NCT06070597 Org: User:
Start: 01/25/24 End: 06/05/24 Due: 06/05/25

A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT05428436 Org: User:
Start: 08/15/22 End: 09/30/22 Due: 09/30/23

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT06006598 Org: User:
Start: 08/28/23 End: 05/05/24 Due: 05/05/25

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01721837 Org: User:
Start: 10/31/12 End: 06/30/13 Due: 06/30/14

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT06309992 Org: User:
Start: 04/02/24 End: 11/05/25 Due: 11/05/26

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02106923 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00620516 Org: User:
Start: 03/31/04 End: - Due: -

Emp-Activity: Empagliflozin Functional Capacity

Phase: N/A Priority: Normal
NCT ID: NCT05350202 Org: User:
Start: 12/18/22 End: 07/25/24 Due: 07/25/25

Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02231931 Org: User:
Start: 09/01/14 End: 01/01/15 Due: 01/01/16

Assessment of the Effect of Empagliflozin (BI 10773) as Single Dose on the QT Interval in Healthy Female and Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01195675 Org: User:
Start: 08/31/10 End: - Due: -

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

Phase: N/A Priority: Normal
NCT ID: NCT02215798 Org: User:
Start: 07/31/06 End: - Due: -

Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02211170 Org: User:
Start: 02/29/00 End: - Due: -

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00056641 Org: User:
Start: 02/18/03 End: - Due: -

Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

Phase: N/A Priority: Normal
NCT ID: NCT01708902 Org: User:
Start: 10/31/12 End: 04/30/14 Due: 04/30/15

A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT05520827 Org: User:
Start: 09/29/22 End: 03/06/23 Due: 03/06/24

Validation of Predictors of OAC Initiation Using EMR Data

Phase: N/A Priority: Normal
NCT ID: NCT03006341 Org: User:
Start: 02/28/17 End: 05/09/17 Due: 05/09/18

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT02248142 Org: User:
Start: 02/28/06 End: - Due: -

Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02191852 Org: User:
Start: 06/30/99 End: - Due: -